Literature DB >> 9741390

A reliable procedure for comparison of antioxidants in rat brain homogenates.

J K Callaway1, P M Beart, B Jarrott.   

Abstract

Lipid peroxidation is a major consequence of oxidative stress and an important cause of neuronal damage in ischaemic injuries and neurodegenerative disorders such as Parkinson's disease. Recent research has focused on the development of antioxidant drugs which may delay or minimize neurodegeneration. Rapid and reliable assays are therefore necessary in order to evaluate novel antioxidant compounds. A widely adopted method for measurement of lipid peroxidation is the thiobarbituric acid reacting substances (TBARS) assay. Several variations of this method have appeared in the literature, some of which have been tested by us without success. We have therefore established a reliable procedure which takes into account the most important factors previously found to influence the TBARS method. Briefly, various concentrations of drug were added to rat brain homogenates (10% w/v in 20 mM Tris-HCl buffer, pH 7.4) and incubated at 37 degrees C for 10 min before addition of ammonium ferric sulphate (100 or 1000 microM) and a further incubation at 37 degrees C for 30 min. Proteins were then precipitated with 8.1% sodium dodecyl sulphate, the reaction stopped with 20% acetic acid, and the samples were then centrifuged for 15 min. Aliquots of supernatant were added to an equal volume of thiobarbituric acid (0.8%), samples were heated at 95 degrees C for 30 min, and then cooled on ice before reading at 532 nm. The present adaptation represents a simple and highly reproducible assay which does not require difficult extraction procedures with hazardous chemicals and results in a stable chromagen. The method has been evaluated using a number of structurally distinct antioxidants and iron chelators. IC50 values (microM) for percentage inhibition of TBARS formation were as follows: desferroxamine (1.1), U83836E (1.7), butylated hydroxytoluene (13), U74500A (20), LY231617 (22), idebenone (89), and Trolox (110). This order of potency was comparable to that found with a commercially available, but expensive kit designed to specifically measure malondialdehyde (Spearman's rank correlation coefficient, p < 0.01).

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9741390     DOI: 10.1016/s1056-8719(98)00022-7

Source DB:  PubMed          Journal:  J Pharmacol Toxicol Methods        ISSN: 1056-8719            Impact factor:   1.950


  10 in total

1.  Ethylenediaminetetraacetic acid induces antioxidant and anti-inflammatory activities in experimental liver fibrosis.

Authors:  J González-Cuevas; J Navarro-Partida; A L Marquez-Aguirre; M R Bueno-Topete; C Beas-Zarate; J Armendáriz-Borunda
Journal:  Redox Rep       Date:  2011       Impact factor: 4.412

2.  Incorporation of sodium channel blocking and free radical scavenging activities into a single drug, AM-36, results in profound inhibition of neuronal apoptosis.

Authors:  J K Callaway; P M Beart; B Jarrott; S F Giardina
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

3.  Targeted disruption of the murine retinal dehydrogenase gene Rdh12 does not limit visual cycle function.

Authors:  Ingo Kurth; Debra A Thompson; Klaus Rüther; Kecia L Feathers; Jared D Chrispell; Jana Schroth; Christina L McHenry; Michaela Schweizer; Sergej Skosyrski; Andreas Gal; Christian A Hübner
Journal:  Mol Cell Biol       Date:  2006-11-27       Impact factor: 4.272

4.  Oxidative stress parameters in different brain structures following lateral fluid percussion injury in the rat.

Authors:  Kristina Pilipović; Zeljko Zupan; Boban Dangubić; Jasenka Mršić-Pelčić; Gordana Zupan
Journal:  Neurochem Res       Date:  2011-02-19       Impact factor: 3.996

5.  BN 80933, a dual inhibitor of neuronal nitric oxide synthase and lipid peroxidation: a promising neuroprotective strategy.

Authors:  P E Chabrier; M Auguet; B Spinnewyn; S Auvin; S Cornet; C Demerlé-Pallardy; C Guilmard-Favre; J G Marin; B Pignol; V Gillard-Roubert; C Roussillot-Charnet; J Schulz; I Viossat; D Bigg; S Moncada
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-14       Impact factor: 11.205

6.  Improved antioxidant effect of idebenone-loaded polyethyl-2-cyanoacrylate nanocapsules tested on human fibroblasts.

Authors:  Maddalena Palumbo; Alessandra Russo; Venera Cardile; Marcella Renis; Donatella Paolino; Giovanni Puglisi; Massimo Fresta
Journal:  Pharm Res       Date:  2002-01       Impact factor: 4.200

7.  Antioxidative activity of ferrocenes bearing 2,6-di-tert-butylphenol moieties.

Authors:  E R Milaeva; S I Filimonova; N N Meleshonkova; L G Dubova; E F Shevtsova; S O Bachurin; N S Zefirov
Journal:  Bioinorg Chem Appl       Date:  2010-06-09       Impact factor: 7.778

8.  Neuroprotective Effects of a Butanol Fraction of Rosa hybrida Petals in a Middle Cerebral Artery Occlusion Model.

Authors:  Goeun Yang; Dongsun Park; Sun Hee Lee; Dae-Kwon Bae; Yun-Hui Yang; Jangbeen Kyung; Dajeong Kim; Ehn-Kyoung Choi; Jin Tae Hong; Heon-Sang Jeong; Hee Jung Kim; Su Kil Jang; Seong Soo Joo; Yun-Bae Kim
Journal:  Biomol Ther (Seoul)       Date:  2013-11       Impact factor: 4.634

9.  N10 -carbonyl-substituted phenothiazines inhibiting lipid peroxidation and associated nitric oxide consumption powerfully protect brain tissue against oxidative stress.

Authors:  Robert G Keynes; Anastasia Karchevskaya; Dieter Riddall; Charmaine H Griffiths; Tomas C Bellamy; A W Edith Chan; David L Selwood; John Garthwaite
Journal:  Chem Biol Drug Des       Date:  2019-06-12       Impact factor: 2.817

10.  Quantitative structure-activity relationships predicting the antioxidant potency of 17β-estradiol-related polycyclic phenols to inhibit lipid peroxidation.

Authors:  Laszlo Prokai; Nilka M Rivera-Portalatin; Katalin Prokai-Tatrai
Journal:  Int J Mol Sci       Date:  2013-01-11       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.